The 2025-2030 World Outlook for Enteric Disease Testing-Treatment - Image 1

Out of stock

This item is currently unavailable

The 2025-2030 World Outlook for Enteric Disease Testing-Treatment

Subjects

Out of stock

Price data last checked 18 day(s) ago - will refresh soon

View at Amazon

One email. No newsletter. No nudges.

Gone for 227 days. Could come back at any time — we're watching for you.

Out of stock 227 days · last price £790 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 392 days · 347 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 392 days • 1 price levels

Days at Price

Price Analysis

Most common price: £790 (347 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 347 days

Description

This study covers the world outlook for enteric disease testing-treatment across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of enteric disease testing-treatment as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott, BD, Bharat Biotech, Biomerica, bioMérieux, Bio-Rad Laboratories, Cepheid, CorisBioconcept, DiaSorin, Eli Lilly and Company, GlaxoSmithKline, IDL Biotech AB (publ), Janssen Global Services, Merck & Company, Meridian Bioscience, Mobidiag, Novartis, Quest Diagnostics, R-Biopharm, Sanofi, Takeda Pharmaceutical Company, Thermo Fisher Scientific, and Trinity Biotech. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CZ2CDQ1V
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 15 April 2024

The 2025-2030 World Outlook for Enteric Disease Testing-Treatment

Gone for 227 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023-2028 World Outlook for Enteric Disease Testing-Treatment

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in the United States

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in China

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in India

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in Japan

The 2023-2028 Outlook for Enteric Disease Testing-Treatment for US Zip Codes

The 2023 Report on Enteric Disease Testing-Treatment: World Market Segmentation by City

The 2025-2030 World Outlook for IBD (Ulcerative Colitis and Crohn's Disease) Treatments

The 2025-2030 World Outlook for Enteral Nutrition

The 2013-2018 Outlook for Inflammatory Bowel Disease Therapeutics in India

The 2023-2028 Outlook for IBD (Ulcerative Colitis and Crohn's Disease) Treatments in China

The 2025-2030 World Outlook for Ulcerative Proctitis

The 2023-2028 World Outlook for Enteral Nutrition

The 2023-2028 Outlook for Ulcerative Proctitis in the United States

The 2026-2031 World Outlook for Veterinary Endoscopy

The 2023 Report on IBD (Ulcerative Colitis and Crohn's Disease) Treatments: World Market Segmentation by City

The 2025-2030 World Outlook for Endoscopic Submucosal Dissection

Endoscopy in Small Bowel Diseases

Biological Therapy for Inflammatory Bowel Disease

The 2025-2030 World Outlook for Digestive Health Supplements

Inflammatory Bowel Disease: Pathogenesis, Diagnosis and Management (Clinical Gastroenterology)

The 2025-2030 World Outlook for Pet Food Extrusion

The 2023-2028 Outlook for Digestive Health Food and Drinks in the United States

New Insights into Inflammatory Bowel Disease